Innovation programs enhance access to living donor transplantation, indicating improved patient care options.
Understanding the current landscape of living donor transplantation and exploring areas of innovation is imperative to a center's ability to continue to serve the full spectrum of patients with end stage organ disease to the best of our collective ability.
No takes yet. Share an insight, caveat, or question.
Woelfel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: